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The papillomavirus E4 open reading frame (ORF) is contained within the E2 ORF, with the primary E4
gene-product (E1∧E4) being translated from a spliced mRNA that includes the E1 initiation codon and
adjacent sequences. E4 is located centrally within the E2 gene, in a region that encodes the E2 protein′s
ﬂexible hinge domain. Although a number of minor E4 transcripts have been reported, it is the product of
the abundant E1∧E4 mRNA that has been most extensively analysed.
During the papillomavirus life cycle, the E1∧E4 gene products generally become detectable at the
onset of vegetative viral genome ampliﬁcation as the late stages of infection begin. E4 contributes to
genome ampliﬁcation success and virus synthesis, with its high level of expression suggesting additional
roles in virus release and/or transmission. In general, E4 is easily visualised in biopsy material by
immunostaining, and can be detected in lesions caused by diverse papillomavirus types, including those
of dogs, rabbits and cattle as well as humans. The E4 protein can serve as a biomarker of active virus
infection, and in the case of high-risk human types also disease severity. In some cutaneous lesions, E4
can be expressed at higher levels than the virion coat proteins, and can account for as much as 30% of
total lesional protein content. The E4 proteins of the Beta, Gamma and Mu HPV types assemble into
distinctive cytoplasmic, and sometimes nuclear, inclusion granules.
In general, the E4 proteins are expressed before L2 and L1, with their structure and function being
modiﬁed, ﬁrst by kinases as the infected cell progresses through the S and G2 cell cycle phases, but also
by proteases as the cell exits the cell cycle and undergoes true terminal differentiation. The kinases that
regulate E4 also affect other viral proteins simultaneously, and include protein kinase A, Cyclin-
dependent kinase, members of the MAP Kinase family and protein kinase C. For HPV16 E1∧E4, these
kinases regulate one of the E1∧E4 proteins main functions, the association with the cellular keratin
network, and eventually also its cleavage by the protease calpain which allows assembly into amyloid-
like ﬁbres and reorganisation of the keratin network. Although the E4 proteins of different HPV types
appear divergent at the level of their primary amino acid sequence, they share a recognisable modular
organisation and pattern of expression, which may underlie conserved functions and regulation.
Assembly into higher-order multimers and suppression of cell proliferation are common to all E4
proteins examined. Although not yet formally demonstrated, a role in virus release and transmission
remains a likely function for E4.
& 2013 The Author. Published by Elsevier Inc. Open access under CC BY license.The E4 protein
The E4 open reading frame (ORF) lies within the larger E2 ORF,
and varies considerably in size between papillomavirus types
(Doorbar and Myers, 1996) (see alignment in Figs. S1 and S2).
In human papillomaviruses, the primary E4 gene product is
expressed from a spliced mRNA (the E1∧E4 message), in whichInc. Open access under CC BY license.the initiation codon and ﬁrst few amino acids are derived from the
E1 ORF (Chow et al., 1987a,b; Doorbar et al., 1990; Milligan et al.,
2007; Wang et al., 2011; Ozbun and Meyers, 1997). E1∧E4 tran-
scripts have been detected in biopsy material caused by diverse
papillomavirus types, and typically represent the most abundant
transcript in productive lesions. This abundance is also apparent at
the protein level, with the E4 gene products accumulating to levels
as high as 20–30% of the total protein content in some productive
warts (Breitburd and Croissant Orth; Doorbar et al., 1986). In fact
the E4 proteins were ﬁrst observed in extracts of plantar warts
induced by HPV1, as two small proteins of molecular weight 16
and 17 K that were visible by SDS gel electrophoresis at levels
equivalent to those of the structural proteins of the cell (Croissant
et al., 1985). Initially these small proteins were suspected to be
Fig. 1. E4 inclusion granules are typically found in cutaneous HPV types (Mu, Beta, Gamma Genera). Cutaneous HPV types from the Mu, Beta and Gamma Genera typically
accumulate their E4 proteins to high level as inclusion granules visible by Hemotoxylin & Eosin staining (granular structures arrowed in (A)). The precise composition of
these inclusion granules is not known, but they are thought to be made up primarily of E4 (Breitburd and Croissant Orth; Rogel-Gaillard et al., 1992,1993; Doorbar et al.,
1996). The appearance of such E4 inclusion granules varies depending on HPV type (Egawa, 1994; Gissmann et al., 1977; Gross et al., 1982). The lesion shown in A is caused by
a Mu HPV type (HPV63), but E4 inclusion granules are also apparent in lesions caused by Beta and Gamma HPV types. The E4 inclusion granules are predominantly
cytoplasmic, but can also be found in the nucleus. The individual electron-dense E4 granule shown in (B(i)) is imaged from the granular layer of a related Mu HPV type
(HPV1) and is stained using a primary antibody to E4 and detected using a gold-conjugated secondary-antibody. E4-staining is visualised as dots on the E4 granule (arrowed).
It appears that in cells with intact nuclei, there is little association between E4 and the virus particles, which form arrays around the intranuclear E4 inclusions. Following
nuclear degeneration in the upper epithelial layers, virus particles enter the cytoplasm of the terminally differentiating epithelial cells and appear by immunostaining to be
closely associated with the abundant cytoplasmic E4 proteins (Doorbar et al., 1997). In the case of the Mu HPV types, E4 can be detected in puriﬁed virus preparations
(Doorbar and Gallimore, 1987), with virions often being associated with blebs (possibly E4) after density gradient centrifugation (B(ii)).
In naturally-occurring papillomas caused by Mu HPV types, E4 expression begins in the lower epithelial layers as visualised by indirect immunoﬂuorescence (C(i)) and (C(ii)).
The green stain is E4, and the cytoplasmic inclusion granules are arrowed in (C(i)) (nuclei shown in blue after DAPI counterstain). The red stain in (C(i)) reveals the
distribution of ampliﬁed viral DNA following Fluorescent In Situ Hybridisation (FISH) using a viral DNA probe. Genome ampliﬁcation is generally conﬁned to E4-positive cells,
which in the lower layers are also positive for cellular replication proteins such as MCM (red stain in (C(ii))). It is generally thought that viral genome ampliﬁcation occurs
predominantly in E4-positive/replication-competent cells, which (in HPV1) are also positive for the G2 cell cycle marker CyclinB/Cdk1 (Davy et al., 2005).
J. Doorbar / Virology 445 (2013) 80–98 81breakdown products of the abundant skin keratins, but were
subsequently shown to be the products of the viral E4 ORF
(Breitburd and Croissant Orth; Doorbar et al., 1986,1988). Because
of the great abundance of E4 in HPV1 warts (see Fig. 1), much
of the early characterisation of E4 expressionwas carried out on this
HPV type (Doorbar et al., 1986; Grand et al., 1989; Rogel-Gaillard
et al., 1992, 1993; Roberts et al., 1993,1994), with studies on the
high-risk HPV types following (Doorbar et al., 1991; Roberts et al.,
1997; Pray and Laimins, 1995; Brown et al., 1994). Indeed, the
abundance of E4 in lesions has suggested a role as a biomarker of
active HPV disease (Middleton, 2003; Borgogna et al., 2012),
and at the cervix, a marker of disease severity (Grifﬁn et al., 2012;
Doorbar and Cubie, 2005). The E4 proteins of all HPVs, and
probably most animal HPV types, have some noticeable structural
similarities (see detail provided in Tables 1–3, Katoh et al., 2002),
but have diverged considerably in their primary amino acid
sequences (see Figs. S1 and S2), and probably also the subtleties
of their function.E4 expression and its contribution to life-cycle success
Most molecular studies on E4 have focused on HPV1 from the Mu
Genus (see Fig. 1), and HPV16 from the Alpha Genus (Species Group 9;
Fig. 2, Table 1), with additional analysis coming from the study of other
Alpha papillomaviruses including HPV11, 18 and 31 (Pray and Laimins,
1995; Brown et al., 1991; Frattini et al., 1997). The E4 proteins have
however been detected in lesions caused by a much wider range of
papillomavirus types, including HPV2 (Alpha), HPV3 (Alpha), HPV4
(Gamma), HPV5 (Beta), HPV6 (low risk (LR) Alpha), HPV8 (Beta),
HPV11 (LR Alpha), HPV58 (HR Alpha), HPV59 (HR Alpha), HPV63 (Mu)
and HPV65 (Gamma) (Fig. 3 (Borgogna et al., 2012; Middleton et al.,2003; Doorbar and Gallimore, 1989; Brown et al., 2004)), as well as
several animal papillomaviruses including Canine Oral Papillomavirus
(COPV, (Nicholls et al., 2001)), Rabbit Oral Papillomavirus (ROPV,
(Maglennon et al., 2011)), Cottontail Rabbit Papillomavirus (CRPV,
(Peh et al., 2004)) and Bovine Papillomavirus (BPV, (Peh et al., 2002)).
In each case, the detection of E4 by immunoﬂuorescence is simple and
straightforward, suggesting that these papillomaviruses resemble
HPV1 to some extent in their ability to express their E4 proteins at
high level. Such comparative analysis has also revealed broad simila-
rities in the timing of expression, with all papillomaviruses that have
been examined showing prominent E4 accumulation in the mid and
upper epithelial layers during productive infection (Maglennon et al.,
2011; Peh et al., 2002; Doorbar et al., 1997) (see protein distribution
images in Figs. 1 and 2). A close association is apparent between the
ﬁrst detection of E4 by immunoﬂuorescence and the onset of
vegetative viral DNA replication or genome ampliﬁcation, which when
considered alongside its abundance, points to an important role for E4
in the late stages of the virus life cycle (Breitburd and Croissant Orth;
Peh et al., 2002; Doorbar et al., 1996). Historically, the E4 ORF was
classiﬁed as an early viral gene (Chen et al., 1982; Danos et al., 1982),
because it lies in the early region of the viral genome and is embedded
amongst viral genes that regulate cell-cycle entry and genome
maintenance. No obvious function for E4 during the early stages of
the virus life-cycle has yet been convincingly described however. Early
studies on BPV showed that it was not involved in cell transformation
by this virus (Neary et al., 1987), while E4 null mutants of CRPV, were
not apparently compromised in their ability to produce papillomas in
either domestic or cottontail rabbits (Peh et al., 2004), which is
consistent with a primary role during the late rather than the early
stages of infection. Amongst HPVs, only the high-risk HPV types
have been extensively studied, partly because of the availability of
convenient model systems for these viruses (Frattini et al., 1997;
Table 1
The 16E1∧E4 protein is structurally and functionally modiﬁed by cellular kinases and proteases as the infected cell undergoes terminal differentiation. These changes are
mediated partly by the viral gene products that drive cell cycle entry and affect normal cell signalling (e.g. E6, E7 and E5), and partly by the differentiating environment
within the epithelium. Changes in the cellular environment are thought to modulate the functions of viral and cellular proteins simultaneously in order to ensure virus
genome ampliﬁcation, virus assembly and virus release.
Epithelial
layer
16E1∧E4 function 16E1∧E4 organisation
Upper 16E1∧E4 is cleaved by calpain following cell cycle
exit. Additional phosporylation around the loop by
PKC is predicted and may stabilize the amyloid
form in the upper layers. The high abundance of
E4 is thought to result from its ability to assemble
into amyloid ﬁbres
Upper &
middle
16E1∧E4 is phosphorylated by CDK (CyclinB/Cdk
and CyclinA/Cdk) in the G2-phase-like/
differentiating cells where genome
ampliﬁcation primarily takes place. This is
predicted to open the loop and enhancecalpain
cleavage
Middle 16E1∧E4 is phosphorylated by MAPK in the
S-phase-like/differentiating cells where genome
ampliﬁcation begins. This compacts the loop
and enhances keratin binding
Middle &
lower
16E1∧E4 levels rise in the mid epithelial layers
following up-regulation of the viral late
promoter. In this conformation, it is thought that
the E1∧E4 protein does not accumulate to high-
level in the cell and has a shorter half-life than
the keratin-bound and/or multimeric form
Lower In the lower epithelial layers 16E1∧E4 is not
easily detected. It is either not present or
present at very low levels
J. Doorbar / Virology 445 (2013) 80–9882Flores et al., 1999; Hummel et al., 1992) (Fig. 2). In experimental
systems, E4 null mutants of HPV16, 18 and 31 are not signiﬁcantly
perturbed in their ability to be maintained in proliferating ‘basal-like’
keratinocytes in monolayer culture, and do not show consistent
differences in their ability to drive cell proliferation (Nakahara et al.,
2005; Wilson et al., 2005, 2007). While these studies do not rule out
an early function for E4, they have not yet allowed such a function to
be identiﬁed. By contrast, both animal studies using CRPV (Peh et al.,2001), and organotypic raft studies on HR HPV types (Nakahara et al.,
2005; Wilson et al., 2005,2007) have suggested a role for E4 in
modulating genome ampliﬁcation and virus synthesis. A single study
that applied the organotypic raft approach to HPV11 (a low-risk HPV
type) failed to report a dramatic effect on these functions (Fang et al.,
2006). This may reﬂect a less signiﬁcant involvement of the low-risk
E4 proteins in these late events and/or differences in genome
maintenance and ampliﬁcation requirements between the high and
Table 2
E4 binding-partners and their potential signiﬁcance during infection.
E4 binding partners
Binding partner Shown for HPV type Additional information Signiﬁcance or potential signiﬁcance Refs.
Cytokeratin HPV1a&HPV16 a Direct binding to type 1 keratins (e.g. keratin 18) but not type
2 keratins or vimentin (Wang et al., 2004). Binding is dependent on
the 16 amino acids at the N-terminus of the E1∧E4 protein, with the
leucine cluster being absolutely required (Roberts et al., 1997)
1. Interaction has been shown in vitro and in vivo (Wang et al., 2004)
and triggers a cellular stress-response with activation of stress-
associated kinases (e.g p38 and pJNK (McIntosh et al., 2010))
2. Interaction leads to the reorganisation and hyper phosphorylation
of the cytokeratin IF network (McIntosh et al., 2010).
3. Interaction is thought to contribute to virus escape and cell
destruction in the upper epithelial layers
Roberts et al. (1994), Roberts
et al. (1993), Roberts et al.
(1997), McIntosh et al. (2010),
Wang et al. (2004)
Cytokeratin
intermediate
ﬁlaments &
cytokeratin
monomers
… but thought to be a key
function of most, if not all,
E4 proteins (McIntosh
et al., 2010)
HPV E4 HPV1 a &HPV16 a For many E4 proteins, self-association is directed (at least in part) by
C-terminal amino sequences with beta aggregation potential
(McIntosh et al., 2008). Loss of C-terminal residues increases E4
solubility in the cell. Cutaneous HPV types may have additional
upstream regions that direct multimerisation
1. Self-association and the formation of amyloid ﬁbres underlies E4-
accumulation in vivo (McIntosh et al., 2008)
2. Multimerisation is thought to enhance the avidity of keratin
association (Wang et al., 2004) and leads to the loss of normal
keratin ﬁlament dynamics (McIntosh et al., 2010)
3. In cutaneous HPV types such as HPV1 and HPV4, E4 assembles
into distinctive cytoplasmic (and occasionally nuclear) inclusion
granules
Roberts et al. (1997), McIntosh
et al. (2010), Wang et al.
(2004)
… self-association
thought to be a conserved
property of E4 proteins
Kinases
CyclinB/Cdk1 HPV16 & HPV18 For HPV16 E1∧E4, association appears to involve residues T22 and T23
(putative cdk phosphorylation site) rather than the 41RRL43 motif
(putative cyclin binding site) (Davy et al., 2005).
1. For HPV16, the sequestration of CyclinB/Cdk1 in the cytoplasm
arrests proliferating cells (such as are found in neoplasia) in G2
(Davy et al., 2002, 2005), and contributes to genome
ampliﬁcation-efﬁciency (Wang, Jackson, Doorbar; Manuscript in
preparation)
2. In HPV18, CyclinB/Cdk1 sequestration is similarly important for
G2 arrest. In productive HPV18 rafts, no role for 18 E1∧E4 G2
arrest was reported (Knight et al., 2011). This may reﬂect a more
limited suprabasal cell proliferation seen in this system when
compared to HPV16
3. In HPV1, CyclinB/Cdk1 activity is thought to be inhibited rather
than being sequestered. It has been suggested that the full length
E1∧E4 protein contributes to a role for 16K-mediated G2-arrest in
genome ampliﬁcation by inhibiting re-replication of cellular DNA
in the arrested cells (Knight et al., 2004). Cdk1 inhibition is
mediated by Wee1(Knight et al., 2006). The signiﬁcance for the
HPV1 life cycle is thought to be in optimising genome
ampliﬁcation (Knight et al., 2006)
Davy et al. (2005), Davy et al.
(2002), Nakahara et al. (2002)HPV1
In HPV18, the putative cyclin binding motif 43RRLL46 (rather than
T23) has been reported to important for binding (Knight et al., 2011;
Ding et al., 2013)
For HPV1 E4, G2 arrest function appears to reside with the 16K
N-terminally-truncated form of the protein and requires residue
T27(E1∧E4 position) which is also referred to as T13 (its position in
the 16K E4 species) (Knight et al., 2004). HPV1 E4-mediated G2
arrest is dependent on sustained Wee1 kinase activity which
phosphorylates Cdk1 at T15 (Knight et al., 2006)
CyclinA/Cdk2 HPV16&HPV18 For HPV18, association requires the 43RRLL46motif (Knight et al., 2011)
that also mediates CyclinB/ Cdk1 binding. In the case of HPV16 E1∧E4,
residues T22and T23 are essential for both CyclinA/Cdk2 binding and
CyclinB/Cdk1 association (Davy et al., 2006). CyclinA/Cdk2 phosph-
orylates 16 E1∧E4 at Serine 32 (S32)
1. For HPV 16, CyclinA/Cdk2 is sequestered in the cytoplasm in G2
but not S-phase. It is though that this may augment the G2 arrest
activity mediated through CyclinB/Cdk1 association
2. For HPV 18 CyclinA/Cdk2 sequestration does not occur in all cell
types and does not appear essential for the G2 arrest phenotype
(Knight et al., 2011)
3. The HPV1 E4 16K protein appears to stimulate an elevation in
CyclinA levels on G2 arrest (Knight et al., 2004)
Knight et al. (2011), Ding et al.
(2013), Davy et al. (2006)
CyclinE/Cdk2 HPV18 Requires 43RRLL46 motif in 18 E1∧E4. Interaction seen so far only in
in vitro binding assays (Ding et al., 2013)
Interaction with CyclinE/Cdk2 not yet seen in mammalian cells. 18
E1∧E4 does not appear to regulate S-phase entry. Signiﬁcance
uncertain
Ding et al. (2013)
p42 MAPK HPV16, HPV11 Transient association and phosphorylation of 16 E1∧E4 at Threonine
(HPV16 T57; HPV11 T53) around the onset of genome ampliﬁcation
HPV16 E1∧E4 is phosphorylated and functionally modiﬁed to enhance
keratin binding by p42 MAPK (Wang et al., 2009). It is thought that
Wang et al. (2009), Knight
et al. (2011), Bell et al. (2007)
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Table 2 (continued )
E4 binding partners
Binding partner Shown for HPV type Additional information Signiﬁcance or potential signiﬁcance Refs.
(Wang et al., 2009). HPV18 E1∧E4 is reported not to be a p42 MAPK
target (Knight et al., 2011; Bell et al., 2007)
this helps initiate E4-accumulation following activation of the
differentiation-dependent promoter(Wang et al., 2009)
Protein kinase A HPV16, HPV18 Phosphorylation site not mapped. S43 predicted in HPV16 (Wang et al.,
2009)
Possible regulator of E1∧E4 structure. PKA sites reported in many E4
proteins (Grand et al., 1989; Wang et al., 2009; Bryan et al., 2000;
Knight et al., 2011)
Knight et al. (2011)
HPV11, HPV1
Signiﬁcance uncertain
Protein kinase C HPV16 Phosphorylation site not mapped. S32, S43 and S44 predicted in HPV16
(Wang et al., 2009)
Thought to maintain phosphorylation at the CyclinB/Cdk1 site as the
cell exits the cell cycle and differentiates
Wang et al. (2009)
SR protein
kinase1
HPV1 Phosphorylation site not mapped. Kinase binding thought to depend
on arginine-rich region with amino acids G44,R45 and R47 being
important (Roberts et al., 2008)
Possible regulator of HPV1 E1∧E4 structure. Association with SRPK
could affect RNA processing and/or nuclear structure
Roberts et al. (2008)
HPV16 & 18 (E1∧E4
proteins appear to
associate less well and are
not SRPK1 substrates
Signiﬁcance uncertain
Other PV proteins
HPV E2 HPV16&HPV18 Co-expression leads to stabilisation of E2 and E4, and to changes in E2
distribution (Davy et al., 2009)
May have effects on viral DNA replication, transcription efﬁciency or
virus assembly. Timing and extent of E2-association during the virus
life-cycle is not yet known
Davy et al. (2009)
HPV L1, L2 HPV 16 Low afﬁnity association suggested Possible role in virus assembly or transmission Sorathia (2005)
Other cellular proteins
E4-DBP HPV16 E4-DBP is a putative DEAD-box RNA helicase Signiﬁcance uncertain. Possible role in RNA processing? Doorbar et al. (2000)
Promyelocytic HPV1 E4 expression causes the re-organisation of PML from ND10 domains
to nuclear E4 inclusion granules. Interaction not thought to be direct
(Roberts et al., 2003)
Redistribution dependent on the presence of nuclear E4 inclusions,
rather than the more prominent cytoplasmic E4 inclusions. Suggested
involvement in viral genome ampliﬁcation, perhaps by modulating
anti-viral responses (Roberts et al., 2003)
Roberts et al. (2003)
Leukemia
protein
(PML)
TopBP1 HPV16 Interaction seen in two-hybrid screen in yeast (JD unpublished data) Signiﬁcance uncertain (but TopBP1 is a target of the HPV16 E2 protein
(Donaldson et al., 2007))
MCM HPV1 Interaction reported in in vitro binding experiments (Roberts et al.,
2008)
May play a role in inhibition of cellular DNA replication mediated by
full-length HPV1 E1∧E4 (Roberts et al., 2008)
Roberts et al. (2008)
a Extensively validated in cell culture and in patient biopsies.
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Table 3
Key features of the HPV E4 proteins.
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Fig. 2. High-risk Alpha HPV E4 expression as amyloid ﬁbres in low-grade Cervical Neoplasia. The E4 proteins of HPV16 have been extensively studied because of the
association of HPV16 with cervical cancer. A haemotoxylin+eosin stained image showing the junction between normal uninfected epithelium (labelled normal) and a region
of low-grade cervical neoplasia (labelled CIN1) is shown in (A(i)). The same piece of tissue is shown in (A(ii)) after staining for HPV16 E4 (green) and MCM (red). The HPV16
E4 protein is abundant in the upper epithelial layers in cells supporting viral genome ampliﬁcation (Doorbar et al., 1997). Although the E4 protein of HPV16 does not
assemble into prominent cytoplasmic inclusion granules as seen for the Mu, Gamma and Beta HPV types, the HPV16 protein is predominantly cytoplasmic with a low-level of
nuclear staining, and associates with keratin ﬁlaments. This intracellular distribution is seen in lesions caused by other Alpha HPV types including HPV2, HPV11 and HPV18.
The E4 proteins of many HPV types and the majority of Alpha types contain a predicted beta-aggregation motif at their C-terminus (B). Current thinking is that this
multimerisation/aggregation motif is carefully regulated in the context of the full-length protein, and that the capacity to multimerise is controlled by phosphorylation and
proteolytic cleavage (see Table 1). C-terminal homology is shown in (B(i)), with aggregation potential for key E4 proteins shown in (B(ii)). The assembly of 16 E1∧E4 into
amyloid-like ﬁbres occurs slowly after expression and puriﬁcation of WT E1∧E4 in bacteria, and more quickly after expression of N-terminal E1∧E4 deletions as shown in
(C(i)) (McIntosh et al., 2008). Soluble WT 16 E1∧E4 can be converted into amyloid-like ﬁbres following cleavage with calpain, which removes the N-terminal 17 amino acids
(C(ii)). It appears that individual E4 ﬁbres can aggregate laterally to produce larger structures. The width of individual ﬁlaments are indicated with arrows in (C(ii)).
J. Doorbar / Virology 445 (2013) 80–98 91low-risk HPVs. LR HPV types such as HPV11 do not replicate well in
standard keratinocyte monolayer culture however, which makes
analysis of life-cycle events in organotypic culture difﬁcult (Fang
et al., 2006; Thomas et al., 2001; Oh et al., 2004). The analysis of
HPV11 E4 in genital warts has however suggested that this protein can
become cross-linked by endogenous transglutaminase to the corniﬁed
envelope and that the integrity of the corniﬁed squame is compro-
mised (Brown and Bryan, 2000; Brown et al., 2006; Bryan and Brown,
2000). It is thought that such ‘fragile’ squames may facilitate efﬁcient
person to person transmission (Bryan and Brown, 2001).E4 processing and functional regulation in infected epithelium
Cutaneous infections (Mu, Gamma, Beta HPV types)
One of the key differences between the E4 proteins of different
papillomaviruses lies in the structures that they form in the infected
cell, and in the timing at which these structures appear (see
Tables 1 and 3, Figs. 1 and 2). Many cutaneous HPV types such as
HPV1 and 63 (Mu Genus), HPV 4 and 65 (Gamma Genus) and HPV
5 and 8 (Beta Genus) form productive papillomas that are charac-
terised by the appearance of cytoplasmic inclusion granules (see Fig. 1
(Croissant et al., 1985; Egawa, 1993, 1994; Gissmann et al., 1977;
Jablonska et al., 1985; Laurent et al., 1982)). These inclusion granules
are typically ﬁrst noticeable in the lower to mid epithelial layers (i.e.
the spinous layers), and are in general, clearly visible in Haemotoxylin
and Eosin stains, although for some HPV types (e.g. HPV4) staining is
poor and can give rise to a ‘clear cell’ appearance (Gross et al., 1982).
These inclusion granules are the primary location of the HPV E4
proteins in such cutaneous lesions, with E4 antibodies staining these
structures prominently (Fig. 1 (Breitburd and Croissant Orth; Croissant
et al., 1985; Rogel-Gaillard et al., 1993; Peh et al., 2002; Doorbar et al.,
1989)). The precise composition of these cytoplasmic structures is notknown, but analysis using chemical cross-linking agents that intro-
duce reversible covalent links between proteins that are in close
proximity to each other, suggests that they may be composed
predominantly of E4, and that the great abundance of E4 in cutaneous
lesions is likely to be attributed largely to the presence of these
structures (Doorbar et al., 1996). E4 inclusion granules are a major
contributor to the ‘cytopathic effect’ described by pathologists, with
different HPV types showing different cytopathic morphologies
(Rogel-Gaillard et al., 1993; Egawa et al., 1993; Gross et al., 1982). In
HPV1, these structures have been extensively examined and are
present as cytoplasmic (and nuclear) inclusion granules in cells
supporting viral genome ampliﬁcation immediately above the infected
basal layer (see Fig. 1). The prominent HPV1 cytoplasmic inclusions
probably associate transiently with the cytokeratin network during
their formation (Rogel-Gaillard et al., 1992, 1993; Doorbar et al., 1996;
Roberts et al., 2003). The less prominent nuclear HPV1 E4 inclusions
(see Fig. 1) have been reported to be associated with promyelocytic
leukemia protein (PML) at their periphery (Roberts et al., 2003). The
E4 inclusion granules typically coalesce and increase in size as the
infected cells are pushed towards the epithelial surface, eventually
becoming less distinct as nuclear degeneration occurs in the upper
corniﬁed layers (Fig. 1, (Breitburd and Croissant Orth; Rogel-Gaillard
et al., 1992,1993)). Studies on the HPV1 E4 protein have shown that it
becomes multiply phosphorylated during differentiation (Breitburd
and Croissant Orth; Grand et al., 1989), and also becomes progressively
cleaved from a 17 K full length species in the parabasal cell layers, to
shorter 16 K (truncated before tyrosine 15), 11 K and 10 K species
(truncated before alanine 59) that have lost sequences from their N-
terminal region (Table 3, (Doorbar et al., 1996, 1988)). Interestingly, the
16 K HPV1 E4 protein has been reported to retard cell cycle progres-
sion at the G2 phase of the cell cycle by inhibiting the activity of Cdk1
(Knight et al., 2006), with the 17 and 16 K proteins working together
to also inhibit cellular DNA replication (Knight et al., 2004, 2006)
(Table 2). In cell-free culture systems, the HPV1 E4 proteins inhibit
Fig. 3. Expression of E4 proteins in epithelial cells; patterns and groupings. (A) The E4 proteins encoded by Alpha HPV types appear to have clear keratin-binding ability and
an ability to reorganise the cellular keratin network (Roberts et al., 1993,1997; Doorbar et al., 1991; McIntosh et al., 2010; Wang et al., 2004). (B) The E4 proteins encoded by
two Gamma HPV types (HPV4 and 65) show a partial association with keratins (Doorbar and Gallimore, 1989; McIntosh et al., 2010). The E4 proteins of these HPV types can
form large cytoplasmic inclusions during natural infection (Egawa, 1994; Egawa et al., 1993). (C) Although the Mu HPV type, HPV1 can associate with keratins in some
systems (Roberts et al., 1993), it appears to do this with a lower afﬁnity, and assembles into cytoplasmic and nuclear inclusion granules (arrowed) both in vitro (Rogel-Gaillard
et al., 1992,1993)and in vivo (Breitburd and Croissant Orth).
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Fig. 4. Model of Keratin Reorganisation mediated by E1∧E4. (A) Reorganisation of the cellular keratin network is a well-characterised consequence of HPV E1∧E4 expression
in epithelial cells. In the cell, cytokeratins exist primarily as insoluble keratin ﬁlaments as well as soluble monomers (i). Keratin ﬁlaments are converted to keratin monomers
as a result of phosphorylation and association with the cellular ‘solubility factor’ 14-3-3, with soluble and insoluble keratins existing in a dynamic equilibrium (ii). In the
presence of E1∧E4 multimers, the keratin network becomes cross-linked, and although the 14-3-3 solubility factor can still bind, phosphorylated keratin monomers cannot
be properly solubilised (iii) and eventually the ﬁlament network becomes disorganised and can collapse to the nuclear periphery. In the absence of E1∧E4′s C-terminal
multimerisation region, some degree of keratin association is still apparent, but the keratin network is not cross-linked and the dynamics of keratin movement within the
cell is not signiﬁcantly compromised (iv). (B) During the papillomavirus life cycle, keratin association and other functions of E4 are carefully regulated. This has been most
thoroughly investigated for the HPV16 E1∧E4 protein (McIntosh et al., 2008; McIntosh et al., 2010; Wang et al., 2004, 2009; Khan et al., 2011). Our current thinking is that the
unphosphorylated form of E4 binds keratins poorly, but that in the S-phase environment that precedes genome ampliﬁcation, the E1∧E4 protein is phosphorylated by MAPK
and that keratin-association is enhanced (i). In the upper epithelial layers the E4 protein is cleaved at its N-terminus by Calpain, which favours the assembly into amyloid-like
ﬁbres (ii). It is thought that these E4 structures participate in keratin cross-linking, virus release and possibly also transmission (Khan et al., 2011).
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suggested that cellular DNA replication may be similarly inhibited
in vivo (Roberts et al., 2008). It is not yet clear however whether
inhibition of cellular DNA replication occurs as part of any HPV life-
cycle, although other viruses are known to use this strategy to favour
replication of their genomes over that of the cell (Roberts et al., 2008).
The full length HPV1 E1∧E4 protein is not readily detectable once cells
have exited the cell cycle post genome-ampliﬁcation, and in these
cells the truncated forms of E4 predominate (Table 3). Mutagenesis
and structural analysis has localised E4′s multimerisation-capability to
the C-terminus of the protein (Roberts et al., 1994, 1997; Doorbar et al.,
1996; Ashmole et al., 1998), and in the case of Alpha HPV types, has
suggested that interactions are mediated through beta-aggregation
(McIntosh et al., 2008). A second key function of E1∧E4 that is thoughtto extend to all HPV types is its ability to associate with cytokeratin
ﬁlaments and to reorganise the cytokeratin ﬁlament network in the
cell (Table 2 and Fig. 3, (Doorbar et al., 1991; Roberts et al., 1993)). For
HPV1 E1∧E4, this interaction requires the N-terminal E1∧E4 amino
acids that are lost in the truncated E4 proteins (Table 3). This region is
predicted to form an amphipathic alpha helix that usually contains a
‘leucine-cluster’ domain (LLXLL or a motif derived from this) that is
essential for keratin association (Table 3). In productive papillomas
caused by HPV1, normal cytokeratin organisation is abolished, with
differentiation-dependent keratins being almost undetectable in cells
expressing E4 (Breitburd and Croissant Orth; Rogel-Gaillard et al.,
1993). This dramatic reduction in keratin staining is a characteristic
of infection by many if not all HPV types, including cutaneous
and mucosal types from the Alpha genus (Doorbar et al., 1997;
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E1∧E4 processing during differentiation is in fact best understood for
HPV16, where both structural information and the nature of regula-
tory phosphorylation is well understood.
Mucosal Infections (Alpha HPV types)
Detailed analysis of the high-risk E4 proteins has focused primarily
on HPV16, HPV18 and 31 (Tables 1–3 and Fig. 4), and it is assumed
that the E4 proteins of related HPV types will have similar mechan-
isms of regulation. Amongst low-risk Alpha types, the HPV11 E1∧E4
protein has been most extensively studied (Table 3) (Brown et al.,
1994, 2006; Bryan and Brown, 2000; Brown et al., 1996). E1∧E4-
mediated disruption of the cellular cytokeratin network (see
Figs. 3 and 4) was ﬁrst shown in epithelial cells grown in monolayer
culture (Doorbar et al., 1991; Doorbar, 1991), with later work conﬁrm-
ing the importance of this interaction in HPV-associated tissue
biopsies from patients (Doorbar et al., 1997; Wang et al., 2004,
2009). In such infected tissue, E1∧E4′s effect on cytokeratins is a re-
organisation, generally to the cell periphery, rather than collapse to a
perinuclear bundle as seen in dividing epithelial cells in culture
(Doorbar et al., 1991; Roberts et al., 1997). These differences underlie
the limitations of using monolayer culture to model events during
epithelial differentiation, and indeed, most recent studies have made
use of organotypic raft culture and the analysis of clinical material to
support basic cell culture experiments (Doorbar et al., 1997; Wilson
et al., 2005, 2007; Wang et al., 2004, 2009; Davy et al., 2005; Khan
et al., 2011). As with the E1∧E4 protein of HPV1, the HPV16, 18 and 31
E1∧E4 proteins all contain a ‘leucine-cluster’ motif close to their
N-terminus, which is important (along with upstream amino acids)
for keratin association (see Tables 2 and 3). In the constrained
structure identiﬁed for the full length 16 E1∧E4, this motif is thought
to be largely unavailable for cytokeratin binding, and associates instead
with the E4 multimerisation-motif located at the C-terminus of the
protein ((McIntosh et al., 2008), Table 1, Fig. 4). The C-terminus of the
HPV11 E1∧E4 protein is similarly important for multimerisation (Bryan
et al., 1998) and a common structural organisation may be widely
conserved amongst E4 proteins (Fig. 2, Table 3). In the constrained
form, the 16 E1∧E4 protein (and very likely other E1∧E4 proteins as
well) has only a limited ability to bind keratins and to self-associate,
and does not accumulate to any signiﬁcant extent within the cell.
Indeed, during natural infection, the E1∧E4 protein is not readily
apparent prior to the onset of viral genome ampliﬁcation, but may
be present at very low level in this constrained form. The dramatic
accumulation of E1∧E4 at or around the onset of genome ampliﬁca-
tion, coincides with the activation of the differentiation-dependent
promoter (i.e. p670 in HPV16) and an elevation in E1∧E4 transcript
levels, as well as with regulatory post-translational modiﬁcation as
cell-cycle activity declines and the infected cell progresses through
its ﬁnal S-phase and G2-phase-like stages before exiting the cell
cycle completely and succumbing to true terminal differentiation
(Table 1, Fig. 4). The basis of how these post-translational modiﬁca-
tions affect E4 function during productive infection (see Fig. 4) can
be understood to some extent by considering the positions of the
post-translationally modiﬁed amino acids within the HPV16 E1∧E4
amino acid sequence (Table 1). In low-grade neoplasia (such as
CIN1), late events such as genome ampliﬁcation begin as E6/E7-
mediated proliferative activity wanes (Isaacson Wechsler et al.,
2012). In such cells, it appears that the S-phase kinase p42 ERK
(Wang et al., 2009) (and possibly other members of the MAP kinase
family (McIntosh et al., 2010)) phosphorylate 16 E1∧E4 at amino acid
Threonine 57, which adds a negative charge within a region of the
protein that is already rich in negatively charged amino acids
(McIntosh et al., 2008; Wang et al., 2009). A similar MAP kinase
phosphorylation site has been identiﬁed in the HPV11 E1∧E4 protein
at position Threonine 53, and its loss compromises the normaldistribution of the protein within the cell ((Bryan et al., 2000),
Table 3). For HPV16 E1∧E4, the consequence of this, as revealed by
FRET analysis, is a tightening of the central loop of the protein, which
facilitates keratin binding and the initial multimerisation of the E4
protein ((McIntosh et al., 2008), Table 1, Fig. 4), and it is likely that
the HPV11 MAP kinase site regulates this protein similarily. The
similar amino acid charge distribution seen across divergent E1∧E4
sequences suggests a similar kinase-mediated regulation of struc-
ture, although for HPV18, the kinase responsible appears not to be
p42MAPK, which was unable to phosphorylate the 18 E1∧E4 protein
in in vitro assays ((Knight et al., 2011; Ding et al., 2013) see
Tables 2 and 3). Experiments using antibodies that speciﬁcally
recognise the HPV16 phospho T57 epitope suggest that this mod-
iﬁcation is however sustained only transiently during the productive
virus life cycle, and is lost as the infected cell slips into the G2-like
phase of the cell cycle where viral genome ampliﬁcation is thought
to occur (Table 1 and Fig. 4 (Wang et al., 2009)). For 16 E1∧E4, a
second well-characterised phosphorylation event accompanies this
S to G2-phase-like transition, and is mediated by the cytoplasmic
kinase Cdk1 ((Davy et al., 2005, 2006), Table 1, Fig. 4). Although,
several Cdk sites are predicted in the 16 E1∧E4 protein, the most
signiﬁcant appears to be at position 32, which is located amongst a
generally positively-charged stretch of amino acids in the N-
terminal half of the protein (McIntosh et al., 2008, 2010; Wang
et al., 2009). Although not located at precisely the same position, a
Cdk1 site (at threonine 23) has been revealed experimentally in the
HPV18 E1∧E4 protein (Table 3 (Knight et al., 2011; Ding et al., 2013)).
For HPV16 (and probably also HPV18 as well), the electrostatic
interactions in this region are important for maintaining the con-
strained loop-structure of the E4 protein, which is thought to
become more relaxed following CyclinB/Cdk1 (and possibly also
CyclinA/Cdk2) phosphorylation (see Table 1 and Fig. 4). It is during
this G2-like phase that E4 begins to accumulate to very high levels,
facilitated by cleavage of sequences from its N-terminus in a manner
akin to that described above for the HPV1 E4 proteins (see Table 1).
For HPV16 E1∧E4, this is mediated in organotypic rafts (and probably
also in vivo) by the cysteine protease calpain, which cleaves the 16
E1∧E4 protein between amino acids 17 and 18 (Khan et al., 2011).
The HPV 18 E1∧E4 protein shows a similar susceptibility to calpain
cleavage, which removes the proteins N-terminus and abolishes its
constrained structure (McIntosh et al., 2008). As a result of this, the
C-terminal multimerisation motifs identiﬁed in Alpha HPV types
(Figs. 2 and 4, Tables 1 and 3) become available for self-association,
allowing the cleaved E1∧E4 protein to assemble into amyloid-like
ﬁbres which affect cell structure and cytokeratin organisation, and
indeed beta-aggregation potential is predicted in all Alpha
HPV E1∧E4 proteins that we have examined (see Figs. 2 and 4).
Although further analysis of post-translational modiﬁcations may
reveal additional layers of complexity, it appears that as with other
papillomavirus proteins (such as E1 for instance (Ma et al., 1999;
Deng et al., 2004; Yu et al., 2007)), that E1∧E4 function is regulated
by the speciﬁc kinases and proteases that become activated as
the infected cell migrates from the basal layer to the epithelial
surface. Furthermore, the recognisable modular structure of E1∧E4
that is apparent across different papillomavirus types suggests that
the broad principles of E4 regulation may in fact be conserved, with
differences (e.g. in kinases and phosphorylation sites) being driven
by individual epithelial tropisms and routes of transmission.The role of E4 in the virus life cycle
Genome ampliﬁcation
Initial studies on the HPV1 E4 protein suggested involvement in
virus assembly and/or release, and lead to the proposition that the
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(Doorbar et al., 1986)). Although this classiﬁcation was not adopted, it
has since become clear that the major role for E4 lies in the late stages
of the virus life cycle, and that these initial predictions may have been
largely accurate. Although the gross effects on cytokeratin architecture
clearly suggest a role in virus release, only a few studies have so far
attempted to examine how cell disruption could facilitate the escape
of infectious virions (Brown and Bryan, 2000; Brown et al., 2006;
Bryan and Brown, 2001), with none yet addressing the possible effects
on transmission success. So far, our understanding of E4 function has
come from standard molecular analysis carried out in cells in mono-
layer culture, and from the analysis of E4′s role during the virus life
cycle using model systems and the analysis of biopsy material. A role
for E4 in viral genome ampliﬁcation, but not in the early stages of
infection was ﬁrst shown using mutant Cottontail Rabbit papilloma-
virus (CRPV) genomes that contain translation–termination linkers in
the E4 ORF (Peh et al., 2004). Such genomes were not markedly
compromised in their ability to produce papillomas, but when
propagated in cottontail rabbits (which support the full CRPV produc-
tive cycle), the loss of E4 reduced the efﬁciency of genome ampliﬁca-
tion and the synthesis of capsid proteins (Peh et al., 2004). E4s role in
genome ampliﬁcation and the expression of capsid proteins, was
subsequently shown for HPV16 (Nakahara et al., 2005), 31 (Wilson
et al., 2005) and 18 (Wilson et al., 2007) using organotypic raft culture
systems, and although our current work indicates that the protein is
not in fact essential for these events, its presence certainly appears to
optimise life-cycle completion. Such a role has not yet been demon-
strated for low-risk HPV types however, although relevant work on
these viruses has so far been limited (Fang et al., 2006; Fang et al.,
2006; Thomas et al., 2001; Oh et al., 2004).
The precise mechanisms by which E4 contributes to genome
ampliﬁcation-success and capsid protein synthesis have not yet been
clearly reported in the literature. However, from the analysis of known
E4 functions, some important insights can be gleaned. Expression of
both HPV16 and 18 E1∧E4 in proliferating epithelial cells in monolayer
culture causes a dramatic arrest in G2 (Davy et al., 2005; Nakahara
et al., 2002; Davy et al., 2002), with similar ﬁndings also being
reported for the HPV 1 E1∧E4 proteins (Knight et al., 2004, 2006). In
the case of HPV 16, G2-arrest appears to involve the sequestration of
CyclinB/Cdk1 in the cytoplasm (through amino acids Threonine 22 and
23 in 16 E1∧E4; amino acids 43RRLL46 in HPV18 E1∧E4 (see
Tables 2 and 3)), which is thought in its self to be sufﬁcient to prevent
nuclear translocation and the phosphorylation of proteins involved in
mitotic progression. Sequestration of CyclinB/Cdk1 is not always
apparent in neoplasia caused by high-risk Alpha types where life-
cycle events are de-regulated, but is typically seen in benign papillo-
mas caused by diverse low-risk types, in good agreement with the
idea that E4 accumulation and genome ampliﬁcation are G2-speciﬁc
(Deng et al., 2004; Yu et al., 2007; Davy and Doorbar, 2007). For high-
risk types, the G2 arrest function of E1∧E4may be expected to potently
inhibit E6/E7-mediated cell proliferation in the mid epithelial layers,
and in this way contribute to the timely onset of vegetative viral
genome ampliﬁcation. Indeed, mutant HPV16 genomes expressing an
‘arrest-deﬁcient’ form of E4 shows lower levels of genome ampliﬁca-
tion in organotypic raft culture, supporting this hypothesis (our
unpublished data). For HPV18, the contribution of E4′s G2-arrest
function is apparently less signiﬁcant (Knight et al., 2011), which
may reﬂect differences in the extent of suprabasal E6/E7-driven cell
proliferation in organotypic rafts induced by these two HPV types.
Indeed, the ability of HPV11 to drive cell cycle entry, but not suprabasal
cell proliferation, may partially explain why for this HPV type, the loss
of E4 (and any potential G2-arrest capability) has only minimal effects
on vegetative genome ampliﬁcation (Fang et al., 2006). In addition to
its dramatic effects on the cell cycle, it is clear that for HPV16 E1∧E4 at
least, that the protein might have other functions that are important
for genome ampliﬁcation but which are less well understood. Theseinclude its associationwith cytoplasmic CyclinA/Cdk2 (via amino acids
T22 and T23 in HPV16 and 43RRLL46 in HPV 18 (Table 2)), which is
thought to enhance 16 E1∧E4s ability to inhibit mitotic progression
(see Table 2 (Davy et al., 2006)), and the association with E2 (Davy
et al., 2009), which is directly required for genome ampliﬁcation
(Table 2). The signiﬁcance of the E2/E4 association during the HPV 16
life cycle is as yet unknown, but is likely to be carefully regulated
during the productive cycle of the virus. In cell monolayer experiments
however, co-expression of E2 and E4 leads to an elevation in the levels
of both proteins, and to a partial sequestration of E2 in the cytoplasm
(Davy et al., 2009). A ﬁnal component of E4 function that may clearly
contribute to the optimisation of genome ampliﬁcation success is its
effect on cellular kinases (Table 2, Fig. 4). The key kinases that
modulate 16 E1∧E4 function are the same as those that regulate E1
accumulation in the nucleus, and it is likely that E4′s ability to
sequester certain members of the MAP (McIntosh et al., 2010; Wang
et al., 2009) and Cyclin-dependent kinase family (Davy et al., 2002,
2005; Nakahara et al., 2002) will result in the functional modiﬁcation
of diverse viral and cellular gene products including E1. Differences in
kinase site position and susceptibility to phosphorylation seen in the
E1∧E4 protein of HPV18 (Knight et al., 2011; Ding et al., 2013) may
reﬂect subtle differences in the epithelial tropism of HPV18 and related
types. When considered together, it is perhaps not surprising that E4-
loss in the context of the viral genome acts to compromise genome
ampliﬁcation success. In our hands however, E4 is certainly not
essential for either genome ampliﬁcation or virus assembly, prompting
us to suspect that the E4 protein may have evolved primarily to ﬁll
other important functions.
Virus assembly, virus release and transmission
Although the E4 proteins of papillomaviruses are always primarily
cytoplasmic, they can clearly be found in the nuclei too (Nicholls et al.,
2001), and can sometimes associate with recognisable structures
(Fig. 2 (Roberts et al., 2003). It is not yet clear whether the presence
of nuclear E4 is an unavoidable consequence of its high abundance in
the cell, or whether the nuclear E4 fraction represents a particular
functional form of the protein that is necessary for a particular activity
such as association with E2 (Davy et al., 2009), or with viral or cellular
proteins necessary for virus assembly and/or maturation. Of signiﬁcant
importance however when considering why E4 accumulates late in
infection, is the observation that the expression of capsid proteins
appears to only occur in cells that are already expressing E4 (Brown
et al., 1994,1995), and that during the productive life cycle, E4
expression precedes L2 expression, which in itself appears to
precede-slightly the expression of L1 (Florin et al., 2002). Thus the
order of expression of viral gene products is arranged in such a way
that infectious virus particles are only ever produced in E4-positive
cells. Although the role of E4 in virus assembly may initially suggest a
need for nuclear E4, we should also remember that L1 and L2 are
expressed in the cytoplasm before locating to the nucleus, and that the
initial assembly of L1 molecules into capsomeres is a cytoplasmic
event (Bird et al., 2008). Although associations between E4, L1 and L2
can be demonstrated in vitro, it appears that E4 loss does not
necessarily compromise virus assembly signiﬁcantly in the organoty-
pic raft system (our unpublished observations). Importantly however,
the nuclear assembly of virus particles is followed eventually by
nuclear degeneration and the release of assembled virions into the
terminally-differentiating cell which contains abundant E4 and a
reduced level of cellular cytokeratins. Work carried out by Brown
and co-workers has revealed important defects in the corniﬁed
envelope in cells expressing the HPV11 E1∧E4 protein, (Brown et al.,
2006; Bryan and Brown, 2000; Lehr et al., 2002, 2004) and has clearly
highlighted the point that the major L1 capsid protein is expressed
from a bicistronic mRNA that contains E1∧E4 as the ﬁrst cistron
(Brown et al., 1996). The natural follow-on from this is that the E1∧E4
J. Doorbar / Virology 445 (2013) 80–9896proteins, which in the upper epithelial layers are present in their N-
terminally truncated form as amyloid ﬁbres, in some way serve to
optimise the transmission success of virions shed from the epithelial
surface in virus-laden squames. Driven largely by the need to fully
understand how prophylactic vaccination offers protection against
infection, a considerable effort has already been put into the study of
virus attachment and the mechanisms of virus entry, but only few
studies have yet made use of virions produced in differentiating
epithelial cells, and none have yet addressed in any signiﬁcant way
the contribution of E1∧E4 to this process. The absence of convenient
epithelial systems for the study of virus production and maturation in
the presence or absence of E4 have so far limited such important
studies.The modular structure of the E4 proteins suggests conserved
functions
While most of the above analysis focuses on the E4 proteins of the
prominent high-risk HPV Alpha types, the comparison with HPV1
E1∧E4 at a functional level, and the analysis of sequence similarities
between these E1∧E4 proteins and those of other papillomaviruses,
suggests that while E4 proteins are highly divergent at the primary
amino acid sequence level, they are much more obviously conserved
when broad ‘structural’ modules are compared (Tables 2 and 3).
When large-scale alignment is carried out, it is clear that the most
signiﬁcant regions of similarity lie at the N-terminus, where a
predicted amphipathic alpha helix and the leucine-cluster motifs
reside (see alignment in Figs. S1 and S2), and at the C-terminus,
where sequences involved in E4/E4 self-association are primarily
located (Table 3). These C-terminal sequences of the Alpha HPV types
typically have high amyloidogenic/Beta aggregation potential and can
be identiﬁed as such using amyloid peptide prediction programs such
as Tango (McIntosh et al., 2008). For HPV16 and HPV1 E1∧E4, the loss
of the C-terminal region and the binding-avidity that this provides
(McIntosh et al., 2008; Wang et al., 2004), prevents prominent E1∧E4
accumulation in the cytoplasm (Roberts et al., 1994,1997), and can a
redistribution of E1∧E4 to the nucleus, despite the retention of N-
terminal motifs that mediate direct keratin binding (Fig. 4 (Wang
et al., 2009)). Although the afﬁnity of E1∧E4/keratin binding has not
yet been measured, the leucine-cluster alone is insufﬁcient to mediate
speciﬁc cytokeratin-binding, but instead directs reporter molecules
such as GFP to the mitochondria (Raj et al., 2004). For HPV16 E1∧E4,
cytokeratin-association requires the leucine-cluster as well as
upstream amino acids, and it is likely that speciﬁcity is controlled in
a similar way amongst other HPV types (Table 3). Thus it appears that
despite variation at the level of primary amino acid sequence, the
E1∧E4 proteins of all HPV types contain clearly recognisable ‘func-
tional motifs’ at their N and C-termini. Variation between E4
sequences lie primarily in their length, which is mediated for the
most part by an extension of the central portion of the E1∧E4
molecule. In the case of the HPV16 E1∧E4 protein, this central region
(which is surrounded by proline-rich segments) comprises a generally
positively-charged region, a loop-region, and a generally negatively-
charged regionwhich form a folded structure ((McIntosh et al., 2008),
Fig. 3). These deﬁned structural elements are recognisable not only in
the putative E1∧E4 proteins of related HPV types, but also in the
E1∧E4 proteins from other genera, suggesting that E1∧E4 proteins
from diverse HPVs may have similar mechanisms of regulation.
Interestingly, the loop region (where the amino acid sequence
undergoes a turn) contains the major immune dominant epitopes
within the protein, and is the site to which many of the most useful
E1∧E4 monoclonal antibodies bind (Fig. 3). It is possible that this
region in particular is available for interaction with cellular targets in
the context of the full-length protein.Other E4 species generated by splicing and proteolytic cleavage
In general, sequence alignment carried out using the predicted
products of the full length E4 ORF show recognisable conservation
only downstream of the E1∧E4 splice acceptor site (Doorbar and
Myers, 1996). Such observations suggest that sequences upstream of
the splice acceptor are not in fact E4 coding sequences, and indeed,
there is no generally conserved ATG codon at the start of all E4 reading
frames to suggest this. It seems instead that in most cases, the
abundant E4 proteins are expressed from a spliced E1∧E4 mRNA
transcript, and that the initiation codon for E4 gene expression comes
from the E1 ORF. It also appears, for both HPV16 and HPV1 E4, that
smaller E4 species with modiﬁed functions can be generated by
proteolytic cleavage as the infected cell migrates towards the epithelial
surface, and that these can be further modiﬁed by phosphorylation
(Breitburd and Croissant Orth; Doorbar et al., 1988; Roberts et al.,
1993,1997; Doorbar et al., 1996; McIntosh et al., 2008; Wang et al.,
2004; Khan et al., 2011). Although an abundant E1∧E4 transcript has
been identiﬁed in most papillomaviruses that have so far been
examined (Chow et al., 1987a,b; Doorbar et al., 1990; Milligan et al.,
2007; Wang et al., 2011; Ozbun and Meyers, 1997; Nasseri et al., 1987;
Baker and Howley, 1987; Barksdale and Baker, 1995; Palermo-Dilts
et al., 1990), recent work has suggested that there may in fact be
additional E4 gene-products expressed from distinct transcripts. These
including a putative E6*∧E4 gene product in HPV16 (Milligan et al.,
2007), as well as two distinct E2∧E4 polypeptides (E2∧E4S and E2∧E4L)
(Tan et al., 2012) and an alternative form of E1∧E4 (E1∧E4S) in HPV18
(Kho et al., 2013). Such transcripts are generally low-abundance when
compared to the primary E1∧E4 species, with their pattern of expres-
sion and signiﬁcance during productive infection not yet known.
Interestingly, the E4 ORF encodes not only the hinge domain of E2,
but in the case of HPV16, it also contains a series of ASF/SF2 sites that
regulate usage of the splice acceptor at position 3358 (SA3358
(Somberg and Schwartz, 2010)). SA3358 is in itself a poor splice
acceptor, despite being efﬁciently used during the HPV life-life cycle
to direct the production of the abundant E1∧E4 mRNA. Current
thinking suggests that increasing ASF/SF2 acts to down regulate the
activity of SA2709 (which is required for E2 expression) in order to
favour the use of SA3358 which allows expression of the abundant
E1∧E4 transcripts, and it has been suggested that the eventual decline
in ASF/SF2 binding in the upper layers of the epidermis may eventually
facilitate the switch to SA5639 usage and allow the expression of
capsid proteins (Somberg and Schwartz, 2010; Rush et al., 2005;
Johansson et al., 2012).Summary
The functions of the papillomavirus E4 proteins in the virus life
cycle have been difﬁcult to resolve. Although located in the early part
of the viral genome, the E4 proteins are primarily expressed during the
late stages of infection, at or around the time that genome ampliﬁca-
tion is initiated. In general, the E4 proteins of different papilloma-
viruses share a recognisable modular organisation despite showing
divergence at the primary amino acid sequence level (Table 3), and can
accumulate to very high levels in the upper epithelial layers where
virus particles assemble. Any consideration of E4 function must take
this into account, and it has been suggested that E4′s ability to disrupt
the cellular keratin network and the formation of the corniﬁed
envelope may facilitate virus release and/or transmission (Figs. 1–4
(Bryan and Brown 2000,2001)). Formal validation of the extent to
which E4 facilitates virus transmission and infection remains to be
carried out. In addition to this potentially signiﬁcant role, the E4
proteins of several HPV types have been shown to inhibit cell
proliferation in G2 (Davy and Doorbar, 2007), and to participate in
efﬁcient genome ampliﬁcation, and perhaps as a consequence of this,
J. Doorbar / Virology 445 (2013) 80–98 97virus synthesis as well (Peh et al., 2004; Nakahara et al., 2005; Wilson
et al., 2005). The contribution of E4 to genome ampliﬁcation has not
yet been fully worked out, but may involve E4′s interaction with
kinases, its association with E2, and its cell cycle-arrest capabilities.
The abundance of E4 in lesional tissue has recently suggested a useful
role as a HPV-speciﬁc biomarker, particularly when used in combina-
tion with cellular makers of deregulated viral gene expression (Grifﬁn
et al., 2012). The preservation of the E4 ORF across diverse papillo-
mavirus types, coupled with its abundance suggests an evolutionary
important role in improving viral ﬁtness. It appears that the E4
proteins may have multiple roles in the virus life-cycle, but that it
plays an important role in ensuring efﬁcient virus release and
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